WOOD BARBARA A 4
4 · SELLAS Life Sciences Group, Inc. · Filed Mar 16, 2020
Insider Transaction Report
Form 4
WOOD BARBARA A
EVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Common Stock
2020-03-12+35,000→ 35,000 total - Award
Stock Option (Right to Buy)
2020-03-12+25,000→ 25,000 totalExercise: $1.89Exp: 2030-03-12→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The reporting person received an award of 35,000 restricted stock units on March 12, 2020, which shall vest as follows: (i) 50% on meeting the primary endpoint in Phase 3 REGAL study, provided that if such endpoint is met prior to March 12, 2021, such vesting will not occur until March 12, 2021 and (ii) 50% upon approval by the FDA of galinpepimut-S.
- [F2]One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 12, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.